544205 — National Peroxide Income Statement
0.000.00%
- IN₹3.69bn
- IN₹3.10bn
- IN₹2.90bn
Annual income statement for National Peroxide, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 3,759 | 3,330 | 2,869 | 2,897 |
| Cost of Revenue | ||||
| Gross Profit | 1,365 | 1,139 | 835 | 1,047 |
| Selling / General / Administrative Expenses | ||||
| Depreciation and Amortization | ||||
| Unusual Expense / Income | ||||
| Other Operating Expenses | ||||
| Total Operating Expenses | 3,240 | 3,147 | 2,918 | 2,799 |
| Operating Profit | 519 | 183 | -49 | 98.1 |
| Gain / Loss on Sale of Assets | ||||
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | 535 | 215 | -20.8 | 144 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | 395 | 168 | -22.5 | 110 |
| Net Income Before Extraordinary Items | ||||
| Net Income | 395 | 168 | -22.5 | 110 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | 395 | 168 | -22.5 | 110 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | 51.8 | 28.9 | -3.91 | 20 |
| Dividends per Share |